Skip to content

Neolife

by Aadhar Medicare Private Limited 99 variants

Ref GP 3

Neolife (GP 3) is a medical device (EU MDR Class I; EMDN category immobilisation systems and devices) made by Aadhar Medicare Private Limited, registered in EUDAMED on 31 May 2026 (Basic UDI-DI 890616442ASXU), active as of 7 Nov 2026.

Active European Union

CE MDR

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None, self-declared

Class I: no certifier involved

Trust

Unverified

Source EUDAMED, synced 7 Nov 2026.

Regulatory status

as of registry sync 7 Nov 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number890616442ASXU Basic UDI-DI Date31 May 2026RegisteredStatusActive

Official records

Certificates

0 certificates · EUDAMED

No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDR Active

Specification

EUDAMED

Device name
Ankle & Foot Supports, & Gel Products
Model / reference
GP 3
Primary DI / UDI-DI
08906164423056, 08906164423063, 08906164423049
Basic UDI-DI
890616442ASXU
Direct marketing DI
08906164423056
08906164423063
08906164423049
EMDN code
M030599 Immobilisation systems and devices - other
Device class
Class I
EU registration type
Standard device
EU market of registration
Malta

Manufacturer details

EUDAMED SRN
IN-MF-000034117
Authorised representative
Advena SRL IT-AR-000051131

Similar devices in this category

Other devices filed under IMMOBILISATION SYSTEMS AND DEVICES - OTHER.

Other devices from Aadhar Medicare Private Limited

See all devices from Aadhar Medicare Private Limited →

Properties

Other properties (14, all answered No)